Because diastolic dysfunction is common among individuals with HIV, authors of the CHART study aimed to evaluate the cardiovascular effects of dysfunction among patients receiving antiretroviral therapy.
...
By analyzing results of the multi-cohort Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study, researchers determined whether contemporary protease inhibitors have similar effects on chronic...
In a new study, the researchers aimed to compare antibody titers to HPV with the rate of abnormal cytology between perinatally HIV-infected and perinatally HIV-exposed, uninfected youth.
The FDA has approved a new option for HIV-1 pre-exposure prophylaxis to reduce HIV-1 infection risk from sex, excluding in those who have receptive vaginal sex.
In his session as IAS 2019, Myron Cohen, MD, discussed new long-acting injectables for HIV prevention and the ongoing trials that will determine the efficacy of each.
The impact of tenofovir-containing pre-exposure prophylaxis on bone mineral density may vary depending on an individual’s adherence. Authors of a new study assessed the effect of the only FDA-approved PrEP...
Tuberculosis is common among patients with HIV. Therefore, the authors of a new study set out to find a point-of-care test that can screen for TB quickly and accurately.
To better understand immune reconstitution in children with HIV taking antiretroviral therapy, researchers compared immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in...
Researchers from Australia investigated the incidence of and behavioral risk factors associated with STIs, as well as the changes in STI incidence after preexposure prophylaxis initiation.
